EMBC
HealthcareEmbecta Corp.
$11.62
$-0.04 (-0.34%)
Jan 5, 2026
Price History (1Y)
Analysis
Embecta Corp. operates in the healthcare sector within the medical instruments and supplies industry. The company has a significant scale with 1850 employees and a market capitalization of $688.04M. The company's financial health indicates strong profitability, with gross margins at 63.3%, operating margin at 24.8%, and profit margin at 8.8%. Returns on assets are relatively high at 16.6%. The balance sheet shows a substantial cash position of $225.50M, but also considerable debt of $1.45B. The valuation context is characterized by a low price-to-earnings ratio (TTM) of 7.22 and forward P/E of 3.96. Revenue growth has been negative at -7.7% year-over-year, while earnings growth has been high at 82.7%. The dividend yield stands at 515.0%, with a payout ratio of 37.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Embecta Corp.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Visit website →Key Statistics
- Market Cap
- $688.04M
- P/E Ratio
- 7.22
- 52-Week High
- $21.10
- 52-Week Low
- $9.20
- Avg Volume
- 542.73K
- Beta
- 1.07
- Dividend Yield
- 515.00%
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NMS
- Country
- United States
- Employees
- 1,850